- $2.69bn
- $2.44bn
- $914.24m
- 92
- 20
- 92
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 589 | 551 | 951 | 1,655 | 914 |
Cost of Revenue | |||||
Gross Profit | 553 | 509 | 657 | 658 | 651 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 555 | 454 | 803 | 1,547 | 882 |
Operating Profit | 34.3 | 97.8 | 148 | 108 | 32.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 38.7 | 99.1 | 149 | 111 | 51.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 42.1 | 77.6 | 110 | 79 | 22.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 42.1 | 77.6 | -0.154 | 194 | 36.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 42.1 | 77.6 | -0.154 | 194 | 31.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.376 | 0.725 | 0.003 | 1.51 | 0.277 |